The Use of Gene Expression Profiling and Biomarkers in Melanoma Diagnosis and Predicting Recurrence: Implications for Surveillance and Treatment
Cutaneous melanoma is becoming more prevalent in the United States and has the highest mortality among cutaneous malignancies. The majority of melanomas are diagnosed at an early stage and, as such, survival is generally favorable. However, there remains prognostic uncertainty among subsets of early...
Main Authors: | James Sun, Kameko M. Karasaki, Jeffrey M. Farma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/3/583 |
Similar Items
-
Prospective validation of the prognostic 31‐gene expression profiling test in primary cutaneous melanoma
by: Jennifer Keller, et al.
Published: (2019-05-01) -
The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma
by: Sebastian Podlipnik, et al.
Published: (2024-01-01) -
Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study
by: Sebastian Podlipnik, et al.
Published: (2022-02-01) -
A Subset of Nuclear Receptors Are Uniquely Expressed in Uveal Melanoma Cells
by: Kenneth Edward Huffman, et al.
Published: (2015-07-01) -
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
by: Jonathan S. Zager, et al.
Published: (2018-02-01)